Posts by Sandra Ansanay-Alex
WEF – Technology Pioneer
Apply before 31 January 2026 for the Technology Pioneer Contest organised by the World Economic Forum The World Economic Forum’s Technology Pioneers community is composed of early-stage start-ups from around the world who are developing and deploying new technologies and innovations. Each year the Forum selects 100 companies to work with society’s foremost political, business and cultural…
Read MoreORION: A smart microfactory to accelerate personalized cancer treatments
The watchmaking microfactory developed by Haute Ecole Arc Ingénierie has inspired ORION, a new research project bringing together 24 partners around personalized cancer treatments. ORION is one of four projects selected by the Swiss Federal Innovation Agency Innosuisse as part of its flagship initiative, “Artificial Intelligence in the Life Sciences, from a Human Health Perspective.”With…
Read MoreProtonica Gets a CHF 400,000 Innosuisse Grant
The EPFL spin-off announces a new Innosuisse grant of approximately CHF 400,000, awarded with strong support from EPFL and CSEM. Protonica is on a mission to transform cancer care by making proton therapy more precise, effective, and accessible. Unlike conventional radiotherapy, proton therapy can target tumors with high accuracy, limiting damage to healthy tissue and…
Read MoreOculis Raises $110 Million to Accelerate its Development
The Swiss-Icelandic ophthalmology company Oculis, based in Zug with its operational headquarters in Lausanne, has completed an oversubscribed capital increase of $110 million. This is its second fundraising round exceeding $100 million in less than a year, following the one in February. Net proceeds from the financing will be used to advance and accelerate the…
Read MoreCHUV and HUG among Europe’s most innovative hospitals
The university hospitals of the Swiss Health Valley confirm their scientific excellence, placing Switzerland among the select group of nations most dynamic in hospital research
Read MoreMolesense Raised CHF 150,000 from VentureKick
The Swiss medtech startup’s sweat-based molecular tracking aims to prevent preterm births and empower doctors with continuous, personalised data.
Read MoreTubulis Raises €308 Million Series C
The German company, that recently set foot at Biopôle Lausanne, generates antibody-drug conjugates to fight ovarian cancer and lung adenocarcinomas.
Read MoreONWARD Medical Raised €50 Million in Capital Increase
ONWARD Medical, a leading neurotechnology company headquartered in the Netherlands, with R&D operations in Lausanne Switzerland and a US office in Boston, is developing therapies to restore movement and independence in people with spinal cord injuries, and has successfully raised over €50 million through a private placement of new shares. The capital increase, backed by…
Read MoreRed Drop Receives a FIT Impact Grant
Red Drop offers home self-sampling kits that use menstrual blood to obtain health information and receive healthcare support.
Read MoreSihuan Pharmaceutical Invests in Suisselle SA
Sihuan Pharmaceutical Holdings Group (HKG:0460) announced that it has made a capital investment in Swiss medical aesthetics company Suisselle, according to a statement released on Monday to the Hong Kong Stock Exchange. The pharmaceutical group did not disclose the financial terms of the transaction. Sihuan Pharmaceutical previously obtained the exclusive distribution rights for Suisselle’s CELLBOOSTER®…
Read More